|
Originally published In Press as doi:10.1074/jbc.M108061200 on November 28, 2001
J. Biol. Chem., Vol. 277, Issue 6, 4505-4511, February 8, 2002
Insulin-like Growth Factor II Plays a Central Role in
Atherosclerosis in a Mouse Model*
Silvio
Zaina §,
Linda
Pettersson ,
Bo
Ahrén¶,
Lena
Brånén ,
A. Bassim
Hassan ,
Marie
Lindholm ,
Ragnar
Mattsson**,
Johan
Thyberg , and
Jan
Nilsson
From the Experimental Cardiovascular Research,
Wallenberg Laboratory, Department of Medicine, University of Lund,
Malmö General Hospital, 205 02 Malmö, Sweden, the
¶ Department of Medicine, BMC, University of Lund, 221 84 Lund,
Sweden, the Department of Zoology, University of Oxford, South
Parks Road, Oxford OX1 3PS, United Kingdom, the ** Lund
Transgenic Core Facility, C13, BMC, University of Lund, 223 62 Lund,
Sweden, and the  Department of Cell and
Molecular Biology, Karolinska Institutet,
171 77 Stockholm, Sweden
Insulin-like growth factor II is a fetal promoter
of cell proliferation that is involved in some forms of cancer and
overgrowth syndromes in humans. Here, we provide two sources of genetic
evidence for a novel, pivotal role of locally produced insulin-like
growth factor II in the development of atherosclerosis. First, we show that homozygosity for a disrupted insulin-like growth factor II allele
in mice lacking apolipoprotein E, a widely used animal model of
atherosclerosis, results in aortic lesions that are ~80% smaller and
contain ~50% less proliferating cells compared with mice lacking
only apolipoprotein E. Second, targeted expression of an insulin-like
growth factor II transgene in smooth muscle cells, but not the mere
elevation of circulating levels of the peptide, causes per
se aortic focal intimal thickenings. The insulin-like growth
factor II transgenics presented here are the first viable mutant mice
spontaneously developing intimal masses. These observations provide the
first direct evidence for an atherogenic activity of insulin-like
growth factor II in vivo.
*
This work was supported by the Swedish Heart Lung
Foundation, Kungliga Fysiografiska Sällskapet i Lund,
Lundströms Stiftelse, Novo Nordic Foundation, Albert Påhlsson
Foundation, Swedish Diabetes Association, the King Gustaf V
80th Birthday Fund, and UMAS Forskningsfonder and by
Swedish Medical Research Council Grants 6834 (to B. A.), 8311 (to
J. N.), and 6537 (to J. T.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
To whom correspondence should be addressed: Experimental
Cardiovascular Research, Entrance 46, 1st Fl., Wallenberg Laboratory, Dept. of Medicine, University of Lund, Malmö General Hospital, 205 02 Malmö, Sweden. Tel.: 46-40-337656; Fax:
46-40-332550; E-mail: silvio.zaina@medforsk.mas.lu.se.
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Y. Han, J. Deng, L. Guo, C. Yan, M. Liang, J. Kang, H. Liu, A. M. Graham, and S. Li
CREG promotes a mature smooth muscle cell phenotype and reduces neointimal formation in balloon-injured rat carotid artery
Cardiovasc Res,
June 1, 2008;
78(3):
597 - 604.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. C. Nichols, W. H. Busby Jr., E. Merricks, J. Sipos, M. Rowland, K. Sitko, and D. R. Clemmons
Protease-Resistant Insulin-Like Growth Factor (IGF)-Binding Protein-4 Inhibits IGF-I Actions and Neointimal Expansion in a Porcine Model of Neointimal Hyperplasia
Endocrinology,
October 1, 2007;
148(10):
5002 - 5010.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. C. Harrington, R. D. Simari, and C. A. Conover
Genetic Deletion of Pregnancy-Associated Plasma Protein-A Is Associated With Resistance to Atherosclerotic Lesion Development in Apolipoprotein E-Deficient Mice Challenged With a High-Fat Diet
Circ. Res.,
June 22, 2007;
100(12):
1696 - 1702.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. T. Heijmans, D. Kremer, E. W. Tobi, D. I. Boomsma, and P. E. Slagboom
Heritable rather than age-related environmental and stochastic factors dominate variation in DNA methylation of the human IGF2/H19 locus
Hum. Mol. Genet.,
March 1, 2007;
16(5):
547 - 554.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Devlin, T. Bottiglieri, F. E. Domann, and S. R. Lentz
Tissue-specific Changes in H19 Methylation and Expression in Mice with Hyperhomocysteinemia
J. Biol. Chem.,
July 8, 2005;
280(27):
25506 - 25511.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-X. Wang, P. K. Elder, Y. Zheng, A. R. Strauch, and R. J. Kelm Jr.
Cell Cycle-mediated Regulation of Smooth Muscle {alpha}-Actin Gene Transcription in Fibroblasts and Vascular Smooth Muscle Cells Involves Multiple Adenovirus E1A-interacting Cofactors
J. Biol. Chem.,
February 18, 2005;
280(7):
6204 - 6214.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Miceli, A. Tropea, F. Minici, M. Orlando, G. Lamanna, M. F. Gangale, B. Panetta, F. Tiberi, S. Vaccari, R. Canipari, et al.
Effects of Insulin-Like Growth Factor I and II on Prostaglandin Synthesis and Plasminogen Activator Activity in Human Umbilical Vein Endothelial Cells
J. Clin. Endocrinol. Metab.,
January 1, 2005;
90(1):
372 - 378.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Lund, L. Andersson, M. Lauria, M. Lindholm, M. F. Fraga, A. Villar-Garea, E. Ballestar, M. Esteller, and S. Zaina
DNA Methylation Polymorphisms Precede Any Histological Sign of Atherosclerosis in Mice Lacking Apolipoprotein E
J. Biol. Chem.,
July 9, 2004;
279(28):
29147 - 29154.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Xu, S. Li, Y. Zhao, T. J. Maures, P. Yin, and C. Duan
Evidence That IGF Binding Protein-5 Functions as a Ligand-Independent Transcriptional Regulator in Vascular Smooth Muscle Cells
Circ. Res.,
March 19, 2004;
94(5):
e46 - e54.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Hsieh, R. E. Gordon, D. R. Clemmons, W. H. Busby Jr., and C. Duan
Regulation of Vascular Smooth Muscle Cell Responses to Insulin-like Growth Factor (IGF)-I by Local IGF-binding Proteins
J. Biol. Chem.,
October 31, 2003;
278(44):
42886 - 42892.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Zaina, L. Pettersson, A. B. Thomsen, C.-M. Chai, Z. Qi, J. Thyberg, and J. Nilsson
Shortened Life Span, Bradycardia, and Hypotension in Mice with Targeted Expression of an Igf2 Transgene in Smooth Muscle Cells
Endocrinology,
June 1, 2003;
144(6):
2695 - 2703.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|